0000000000010131

AUTHOR

Cal V

showing 18 related works from this author

DNA-aneuploidy and high SPF and specific p53 mutations are independent prognostic factors in colorectal cancer (CRC).

2004

researchProduct

TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal S…

2005

researchProduct

Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer

2007

AnalysisTP53 Ki-Ras P16INK4A colorectal cancer
researchProduct

Ductal Lavage: a valid method of risk assessment and of early diagnosis in breast cance

2006

researchProduct

A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation?

2006

researchProduct

BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER

2007

researchProduct

A missense mutation associated to early onset breast cancer in a sicilian woman.

2006

researchProduct

TP53 in exon 5 and s-Phase fraction but not mutations in Ras gen family and DNA-ploidy are indipendent indicators in laryngeal squamous cell carcinoma

2005

researchProduct

Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer

2004

researchProduct

BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling.

2006

researchProduct

Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer

2007

researchProduct

BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families.

2007

hereditary breast/ovarian cancer
researchProduct

Detection and clinical relevance of free circulating tumor DNA in blood of patients with gastrointestinal cancer

2004

researchProduct

Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC)

2007

Recently, new chemotherapy agents which target the non-structural components of mitosis have been developed. An important protein involved in several mitotic phases is the Aurora-A protein. By means of the phosphorylation of different substrates, Aurora-A regulates the correct development of the various phases of mitosis. The kinase activity of this protein makes Aurora-A an excellent candidate as an oncogene. The first data of Aurora-A involvement in cancer regarded the identification of Aurora-A overexpression in primary breast and colon tumour samples. With regard to the predictive role of Aurora-A, it has been shown that its overexpression disrupts the spindle checkpoint activated by pa…

Kinase inhibitorCancer treatmentMitosiAurora-ASmall molecule
researchProduct

Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC)

2007

BACKGROUND: Despite the improvement in detection and surgical therapy in the last years, the outcome of patients affected by colorectal carcinoma (CRC) remains limited by metastatic relapse. The aim of this study was to investigate the presence of free tumor DNA in the plasma of CRC patients in order to understand its possible prognostic role. PATIENTS AND METHODS: Ki-Ras, TP53 mutations and p16(INK4A) methylation status were prospectively evaluated in tumor tissues and plasma of 66 CRC patients. RESULTS: In 50 of the 66 primitive tumor cases (76%) at least one significant alteration was identified in Ki-Ras and/or TP53 and/or p16(INK4A) genes. Eighteen of the 50 patients presented the same…

Settore MED/06 - Oncologia MedicaSettore MED/08 - Anatomia PatologicaMolecular analysis TP53 GIC
researchProduct

Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression

2007

researchProduct

Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth Internation…

2004

researchProduct

P16, p53 altertaions and S phase fraction are predictive of clinical outcome in Laringeal squamous cell carcinoma.

2006

researchProduct